Our division focuses on understanding how genetics and gene regulation shape health and disease, aiming to improve the diagnosis and treatment of conditions such as intellectual disabilities, epilepsy, dementia, muscular dystrophy, autoimmune disorders, and cancer. By investigating these mechanisms, we contribute to a deeper understanding of human biology.
We employ advanced genomic technologies, large-scale screening methods, and computational tools to identify the genetic, epigenetic, and transcriptomic changes that influence disease. This focus on gene regulation helps us uncover key biological pathways and develop innovative therapies, including RNA-based treatments.
Through partnerships with industry leaders like CSL and Moderna and by openly sharing our research outputs, we aim to foster global progress in genomic research and its applications in medicine.
To contact the division please email Division Coordinators, Dr Tanya de Jong-Curtain or Fiona McGrath.
